Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1580

PENTOSTATIN
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O

Basic Information

ChEMBL ID CHEMBL1580
Name PENTOSTATIN
Phase Approved
Structure Type MOL
InChI Key FPVKHBSQESCIEP-JQCXWYLXSA-N
Therapeutic ✓ Yes

Known Names

CI-825 Deoxycoformycin Nipent NSC-218321 PD 81565 PD-81565 Pentostatin Pentostatina Pentostatine YK-176
4
Targets
15
Activities
2
Assay Types
2
PK Parameters
20
Publications
10
Known Names
13
Indications
1
Mechanisms

Molecular Properties

268.3
MW (Da)
-1.18
ALogP
8
HBA
4
HBD
112.1
PSA (Ų)
0.54
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1991
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral

Flags

Black Box Warning Natural Product
USAN Stem -stat-
USAN Year 1977

Extended Properties

Molecular Formula C11H16N4O4
MW 268.27
Aromatic Rings 1
Heavy Atoms 19
NP-Likeness 1.00

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Adenosine deaminase inhibitor INHIBITOR Adenosine deaminase

Indications

Anemia Leukemia, Hairy Cell Neoplasms Neoplasms Graft vs Host Disease Leukemia, Lymphocytic, Chronic, B-Cell Bronchiolitis Obliterans Syndrome Leukemia Lymphoma Anemia, Aplastic Anemia, Sickle Cell Kidney Neoplasms Lymphoma, B-Cell

ATC Classification

L01XX08
pentostatin
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS

Drug Warnings

Black Box Warning
General Warning
Country: United States

Activity Summary

Ki 13 meas. best 11.0
IC50 2 meas. best 6.6

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Adenosine deaminase
CHEMBL2966
Ki 11.0 11.0 0.0 1
Adenosine deaminase
CHEMBL1910
Ki 10.59 10.0925 0.0 4
Adenosine deaminase
CHEMBL4523370
Ki 10.42 9.255 0.0 2
L1210
CHEMBL386
IC50 6.6 6.16 250.0 2

Pharmacokinetic Data

Parameter Value Units Species
AUC 9500.0 ng.hr.mL-1 Mus musculus
Cmax 45476.57 nM Mus musculus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
16472241 10.2174/1570163043334794 Hepatotoxicity 18
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
15646539 10.1016/s0399-8320(04)95062-2 NON-PROTEIN TARGET 8
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
30964283 10.1021/acs.jmedchem.9b00182 Adenosine deaminase 4
15139750 10.1021/jm0499559 Mus musculus 3
37468498 10.1038/s41467-023-40064-9 Nuclear receptor subfamily 1 group I member 2 3
37468498 10.1038/s41467-023-40064-9 Histamine H1 receptor 3
25462277 10.1016/j.ejmech.2014.10.080 NON-PROTEIN TARGET 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
26948801 10.1016/j.drudis.2016.02.015 Homo sapiens 2
16033254 10.1021/jm050413g Mus musculus 2
3489838 10.1021/jm00160a046 L1210 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
37468498 10.1038/s41467-023-40064-9 Peroxisome proliferator-activated receptor gamma 2
12643924 10.1016/s0960-894x(03)00026-x Mus musculus 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2

Data from ChEMBL 36 via Core Engine